The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration.

Zhang J, Shi S, Wu J, Tan Z, Liu F, Fang F, Zhen P

Open source

DOI
10.3389/fonc.2026.1912332
Published
2026
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1912332,
  title = {The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration.},
  author = {Zhang J and Shi S and Wu J and Tan Z and Liu F and Fang F and Zhen P},
  year = {2026},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2026.1912332},
  url = {https://doi.org/10.3389/fonc.2026.1912332}
}

RIS

TY  - JOUR
TI  - The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration.
AU  - Zhang J
AU  - Shi S
AU  - Wu J
AU  - Tan Z
AU  - Liu F
AU  - Fang F
AU  - Zhen P
PY  - 2026
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2026.1912332
UR  - https://doi.org/10.3389/fonc.2026.1912332
ER  - 

APA

J, Z., S, S., J, W., Z, T., F, L., F, F., & P, Z. (2026). The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1912332

Source records